| Year |
Citation |
Score |
| 2022 |
Kalpana GV. Protein-Protein and Protein-RNA Interaction Assays to Determine Similarity of INI1/SMARCB1 and TAR RNA in Binding to HIV-1 Integrase. Methods in Molecular Biology (Clifton, N.J.). 2610: 85-97. PMID 36534284 DOI: 10.1007/978-1-0716-2895-9_8 |
0.35 |
|
| 2022 |
Qiu L, Bhutoria S, Kalpana GV, Zou X. Computational Modeling of IN-CTD/TAR Complex to Elucidate Additional Strategies to Inhibit HIV-1 Replication. Methods in Molecular Biology (Clifton, N.J.). 2610: 75-84. PMID 36534283 DOI: 10.1007/978-1-0716-2895-9_7 |
0.432 |
|
| 2021 |
Dixit U, Bhutoria S, Wu X, Qiu L, Spira M, Mathew S, Harris R, Adams LJ, Cahill S, Pathak R, Rajesh Kumar P, Nguyen M, Acharya SA, Brenowitz M, Almo SC, ... ... Kalpana GV, et al. INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication. Nature Communications. 12: 2743. PMID 33980829 DOI: 10.1038/s41467-021-22733-9 |
0.456 |
|
| 2019 |
Ajasin DO, Rao VR, Wu X, Ramasamy S, Pujato M, Ruiz AP, Fiser A, Bresnick AR, Kalpana GV, Prasad VR. CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release. Elife. 8. PMID 31172941 DOI: 10.7554/Elife.35546 |
0.566 |
|
| 2018 |
Ajasin DO, Rao VR, Wu X, Ramasamy S, Pujato M, Ruiz AP, Fiser A, Bresnick AR, Kalpana GV, Prasad VR. Author response: CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release Elife. DOI: 10.7554/Elife.35546.047 |
0.454 |
|
| 2017 |
Prasad VR, Kalpana GV. FISHing Out the Hidden Enemy: Advances in Detecting and Measuring Latent HIV-Infected Cells. Mbio. 8. PMID 28928214 DOI: 10.1128/Mbio.01433-17 |
0.468 |
|
| 2016 |
La Porte A, Cano J, Wu X, Mitra D, Kalpana GV. An essential role of INI1/hSNF5 chromatin remodeling protein in HIV-1 post-transcriptional events and Gag/GagPol stability. Journal of Virology. PMID 27558426 DOI: 10.1128/Jvi.00323-16 |
0.588 |
|
| 2016 |
Bhutoria S, Kalpana GV, Acharya SA. Computational Modeling of Repeat1 region of INI1/hSNF5: An evolutionary link with Ubiquitin. Protein Science : a Publication of the Protein Society. PMID 27261671 DOI: 10.1002/Pro.2961 |
0.365 |
|
| 2016 |
La Porte A, Kalpana GV. Quantification of HIV-1 Gag Localization Within Virus Producer Cells. Methods in Molecular Biology (Clifton, N.J.). 1354: 165-74. PMID 26714711 DOI: 10.1007/978-1-4939-3046-3_11 |
0.396 |
|
| 2016 |
Sorin M, Kalpana GV. HIV-1 Dynamics in the Host Cell: A Review of Viral- and Host- Protein Interactions and Potential Therapeutic Targets for HIV-1 Infection Einstein Journal of Biology and Medicine. 22: 10. DOI: 10.23861/Ejbm2006227 |
0.748 |
|
| 2014 |
Gaskill PJ, Yano HH, Kalpana GV, Javitch JA, Berman JW. Dopamine receptor activation increases HIV entry into primary human macrophages. Plos One. 9: e108232. PMID 25268786 DOI: 10.1371/Journal.Pone.0108232 |
0.42 |
|
| 2013 |
Mathew S, Nguyen M, Wu X, Pal A, Shah VB, Prasad VR, Aiken C, Kalpana GV. INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo. Retrovirology. 10: 66. PMID 23799881 DOI: 10.1186/1742-4690-10-66 |
0.562 |
|
| 2013 |
Li H, Redinbo MR, Venkatesh M, Ekins S, Chaudhry A, Bloch N, Negassa A, Mukherjee P, Kalpana G, Mani S. Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXR. The Journal of Biological Chemistry. 288: 13655-68. PMID 23525103 DOI: 10.1074/Jbc.M113.455485 |
0.304 |
|
| 2013 |
Plotkin SR, Blakeley JO, Evans DG, Hanemann CO, Hulsebos TJ, Hunter-Schaedle K, Kalpana GV, Korf B, Messiaen L, Papi L, Ratner N, Sherman LS, Smith MJ, Stemmer-Rachamimov AO, Vitte J, et al. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. American Journal of Medical Genetics. Part A. 161: 405-16. PMID 23401320 DOI: 10.1002/Ajmg.A.35760 |
0.336 |
|
| 2011 |
Smith ME, Das BC, Kalpana GV. In vitro activities of novel 4-HPR derivatives on a panel of rhabdoid and other tumor cell lines. Cancer Cell International. 11: 34. PMID 21951911 DOI: 10.1186/1475-2867-11-34 |
0.315 |
|
| 2011 |
Lee S, Cimica V, Ramachandra N, Zagzag D, Kalpana GV. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival. Cancer Research. 71: 3225-35. PMID 21521802 DOI: 10.1158/0008-5472.Can-10-2167 |
0.361 |
|
| 2011 |
Cano J, Kalpana GV. Inhibition of early stages of HIV-1 assembly by INI1/hSNF5 transdominant negative mutant S6. Journal of Virology. 85: 2254-65. PMID 21159874 DOI: 10.1128/Jvi.00006-10 |
0.495 |
|
| 2010 |
Cimica V, Smith ME, Zhang Z, Mathur D, Mani S, Kalpana GV. Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen. Bmc Cancer. 10: 634. PMID 21092078 DOI: 10.1186/1471-2407-10-634 |
0.308 |
|
| 2009 |
Sorin M, Cano J, Das S, Mathew S, Wu X, Davies KP, Shi X, Cheng SW, Ott D, Kalpana GV. Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication. Plos Pathogens. 5: e1000463. PMID 19503603 DOI: 10.1371/Journal.Ppat.1000463 |
0.77 |
|
| 2009 |
Das S, Cano J, Kalpana GV. Multimerization and DNA binding properties of INI1/hSNF5 and its functional significance. The Journal of Biological Chemistry. 284: 19903-14. PMID 19398554 DOI: 10.1074/Jbc.M808141200 |
0.522 |
|
| 2009 |
Das S, Kalpana GV. Reverse two-hybrid screening to analyze protein-protein interaction of HIV-1 viral and cellular proteins. Methods in Molecular Biology (Clifton, N.J.). 485: 271-93. PMID 19020832 DOI: 10.1007/978-1-59745-170-3_19 |
0.452 |
|
| 2009 |
Prasad VR, Kalpana GV. HIV Protocols: Preface Methods in Molecular Biology. 485. |
0.429 |
|
| 2008 |
Xu Z, Zheng Y, Ao Z, Clement M, Mouland AJ, Kalpana GV, Belhumeur P, Cohen EA, Yao X. Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication. Retrovirology. 5: 102. PMID 19014595 DOI: 10.1186/1742-4690-5-102 |
0.581 |
|
| 2008 |
Das BC, Smith ME, Kalpana GV. Design and synthesis of 4-HPR derivatives for rhabdoid tumors. Bioorganic & Medicinal Chemistry Letters. 18: 3805-8. PMID 18515102 DOI: 10.1016/J.Bmcl.2008.05.021 |
0.307 |
|
| 2008 |
Wang H, Li H, Moore LB, Johnson MD, Maglich JM, Goodwin B, Ittoop OR, Wisely B, Creech K, Parks DJ, Collins JL, Willson TM, Kalpana GV, Venkatesh M, Xie W, et al. The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor. Molecular Endocrinology (Baltimore, Md.). 22: 838-57. PMID 18096694 DOI: 10.1210/Me.2007-0218 |
0.301 |
|
| 2007 |
Morozov A, Lee SJ, Zhang ZK, Cimica V, Zagzag D, Kalpana GV. INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4721-30. PMID 17699849 DOI: 10.1158/1078-0432.Ccr-07-0054 |
0.336 |
|
| 2007 |
Wang H, Huang H, Li H, Teotico DG, Sinz M, Baker SD, Staudinger J, Kalpana G, Redinbo MR, Mani S. Activated pregnenolone X-receptor is a target for ketoconazole and its analogs. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2488-95. PMID 17438109 DOI: 10.1158/1078-0432.Ccr-06-1592 |
0.316 |
|
| 2006 |
Sorin M, Yung E, Wu X, Kalpana GV. HIV-1 replication in cell lines harboring INI1/hSNF5 mutations. Retrovirology. 3: 56. PMID 16945155 DOI: 10.1186/1742-4690-3-56 |
0.79 |
|
| 2006 |
Sorin M, Kalpana GV. Dynamics of virus-host interplay in HIV-1 replication. Current Hiv Research. 4: 117-30. PMID 16611052 DOI: 10.2174/157016206776055048 |
0.748 |
|
| 2006 |
Alarcon-Vargas D, Zhang Z, Agarwal B, Challagulla K, Mani S, Kalpana GV. Targeting cyclin D1, a downstream effector of INI1/hSNF5, in rhabdoid tumors Oncogene. 25: 722-734. PMID 16302003 DOI: 10.1038/Sj.Onc.1209112 |
0.315 |
|
| 2005 |
Tsikitis M, Zhang Z, Edelman W, Zagzag D, Kalpana GV. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss. Proceedings of the National Academy of Sciences of the United States of America. 102: 12129-34. PMID 16099835 DOI: 10.1073/Pnas.0505300102 |
0.711 |
|
| 2004 |
Hehl EA, Joshi P, Kalpana GV, Prasad VR. Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins. Journal of Virology. 78: 5056-67. PMID 15113887 DOI: 10.1128/Jvi.78.10.5056-5067.2004 |
0.468 |
|
| 2004 |
Yung E, Sorin M, Wang EJ, Perumal S, Ott D, Kalpana GV. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance. Journal of Virology. 78: 2222-31. PMID 14963118 DOI: 10.1128/Jvi.78.5.2222-2231.2004 |
0.79 |
|
| 2002 |
Zhang ZK, Davies KP, Allen J, Zhu L, Pestell RG, Zagzag D, Kalpana GV. Cell cycle arrest and repression of cyclin D1 transcription by INI1/hSNF5. Molecular and Cellular Biology. 22: 5975-88. PMID 12138206 DOI: 10.1128/Mcb.22.16.5975-5988.2002 |
0.35 |
|
| 2002 |
Craig E, Zhang ZK, Davies KP, Kalpana GV. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis. The Embo Journal. 21: 31-42. PMID 11782423 DOI: 10.1093/Emboj/21.1.31 |
0.63 |
|
| 2001 |
Ghosh SS, Sappal BS, Kalpana GV, Lee SW, Chowdhury JR, Chowdhury NR. Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications. The Journal of Biological Chemistry. 276: 42108-15. PMID 11546782 DOI: 10.1074/Jbc.M106742200 |
0.335 |
|
| 2001 |
Yung E, Sorin M, Pal A, Craig E, Morozov A, Delattre O, Kappes J, Ott D, Kalpana GV. Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1. Nature Medicine. 7: 920-6. PMID 11479624 DOI: 10.1038/90959 |
0.768 |
|
| 2001 |
Turelli P, Doucas V, Craig E, Mangeat B, Klages N, Evans R, Kalpana G, Trono D. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: Interference with early steps of viral replication Molecular Cell. 7: 1245-1254. PMID 11430827 DOI: 10.1016/S1097-2765(01)00255-6 |
0.723 |
|
| 1999 |
Kalpana GV, Reicin A, Cheng GS, Sorin M, Paik S, Goff SP. Isolation and characterization of an oligomerization-negative mutant of HIV-1 integrase. Virology. 259: 274-85. PMID 10388652 DOI: 10.1006/Viro.1999.9767 |
0.714 |
|
| 1999 |
Lee D, Sohn H, Kalpana GV, Choe J. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature. 399: 487-91. PMID 10365963 DOI: 10.1038/20966 |
0.339 |
|
| 1999 |
Kalpana GV. Retroviral vectors for liver-directed gene therapy Seminars in Liver Disease. 19: 27-37. PMID 10349681 DOI: 10.1055/S-2007-1007095 |
0.358 |
|
| 1999 |
Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nature Genetics. 22: 102-5. PMID 10319872 DOI: 10.1038/8811 |
0.695 |
|
| 1999 |
Wu X, Liu H, Xiao H, Conway JA, Hehl E, Kalpana GV, Prasad V, Kappes JC. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex Journal of Virology. 73: 2126-2135. PMID 9971795 DOI: 10.1128/Jvi.73.3.2126-2135.1999 |
0.519 |
|
| 1998 |
Morozov A, Yung E, Kalpana GV. Structure-function analysis of integrase interactor 1/hSNF5L1 reveals differential properties of two repeat motifs present in the highly conserved region. Proceedings of the National Academy of Sciences of the United States of America. 95: 1120-5. PMID 9448295 DOI: 10.1073/Pnas.95.3.1120 |
0.732 |
|
| 1996 |
Wu DY, Kalpana GV, Goff SP, Schubach WH. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1. Journal of Virology. 70: 6020-8. PMID 8709224 DOI: 10.1128/Jvi.70.9.6020-6028.1996 |
0.401 |
|
| 1996 |
Guleria I, Teitelbaum R, McAdam RA, Kalpana G, Jacobs WR, Bloom BR. Auxotrophic vaccines for tuberculosis. Nature Medicine. 2: 334-7. PMID 8612234 DOI: 10.1038/Nm0396-334 |
0.362 |
|
| 1996 |
Wang W, Côté J, Xue Y, Zhou S, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, Workman JL, Crabtree GR. Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. The Embo Journal. 15: 5370-5382. DOI: 10.1002/J.1460-2075.1996.Tb00921.X |
0.355 |
|
| 1995 |
Reicin AS, Kalpana G, Paik S, Marmon S, Goff S. Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration. Journal of Virology. 69: 5904-7. PMID 7637038 DOI: 10.1128/Jvi.69.9.5904-5907.1995 |
0.38 |
|
| 1994 |
Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science (New York, N.Y.). 266: 2002-6. PMID 7801128 DOI: 10.1126/Science.7801128 |
0.48 |
|
| 1993 |
Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell. 73: 1067-78. PMID 8513493 DOI: 10.1016/0092-8674(93)90637-6 |
0.553 |
|
| 1993 |
Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP, Calame K. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science (New York, N.Y.). 262: 1889-92. PMID 8266081 DOI: 10.1126/Science.8266081 |
0.304 |
|
| 1993 |
Kalpana GV, Goff SP. Genetic analysis of homomeric interactions of human immunodeficiency virus type 1 integrase using the yeast two-hybrid system. Proceedings of the National Academy of Sciences of the United States of America. 90: 10593-7. PMID 8248150 DOI: 10.1073/Pnas.90.22.10593 |
0.399 |
|
| Show low-probability matches. |